Deprescribing DRrugs for Overactive Bladder in General Practice (DROP)

Launched by ANNE ESTRUP OLESEN · Oct 30, 2023

Keywords

ClinConnect Summary

The DROP trial is a study aimed at helping older adults with overactive bladder (OAB) by looking at the effects of reducing or stopping certain medications. If you or a family member is 65 years or older and has been prescribed medication for OAB in the past 14 months, this trial might be a good fit. Participants need to be able to speak and understand Danish, but if someone has significant cognitive issues or is receiving specialized care for their bladder symptoms, they may not be eligible to join.

As a participant, you can expect to take part in discussions about your medications and receive support to evaluate whether reducing them could benefit your health and quality of life. The trial is currently recruiting participants, and by joining, you may help improve treatment options for others with similar conditions in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • patient must have been prescribed one of the following drugs for OAB within the last 14 months
• • patient must be able to speak and understand Danish
• Exclusion Criteria:
• • too cognitively impaired to participate or otherwise unfit to participate as estimated by general practitioner
• • receiving neurological or urogenital ambulatory care for their overactive bladder symptoms